Saptarshi (Banerjee) Bandyopadhyay MD MS, AKA "Dr. Bandyo" and "Dr. B." (He/Him)
[Pronunciation: "Ban-do"]
Medical Scientist, Physician, and Consultant
Join to View Full Profile
15 Whalen CourtWest Orange, NJ 07052
Phone+1 908-372-8960
Dr. Bandyopadhyay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Saptarshi (Banerjee) Bandyopadhyay, who goes by "Dr Bandyo", is a (Type 2) translational research specialist committed to joining the disparate fields of medicine and engineering in order to truly advance medical care into the 22nd century. Based in West Orange, NJ, he completed his medical education and internal medicine training at the University of Illinois College of Medicine and McGaw Medical Center of Northwestern University, with additional research activities in the NorthShore Health System, now part of the University of Chicago, and the University of Illinois at Urbana. His diverse employment history includes roles such as Investigator at DM Clinical Research, Medical Director of the Center for Wound Healing & Hyperbaric Medicine, and Chief Medical Scientist at Modus (TM). Dr. Bandyopadhyay completed an MS in Biomedical Engineering at Case Western Reserve University in 2025 and holds BS degrees in Electrical Engineering and in Life Sciences, both with honors. He has published works on various topics, including arterial hyperoxygenation, hyperthermia, radio telescopes and cardiac MRI. His clinical experience spans areas such as bariatric medicine, diabetes, radioligand therapy, diagnostic BioMEMS devices, cardiology, medical imaging, and hospital medicine, with specific involvement in clinical trials that focused on medical devices, contrast agents, type 2 diabetes, neurodegenerative disease, autoimmune disease, vaccines / infectious diseases, cardiometabolic pathology, and obesity treatment.
Education & Training
Case Western Reserve UniversityMS, Biomedical Engineering, (*Coursework completed in Aug 2024*), 2021 - 2025
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2004 - 2006
University of Chicago (NorthShore)Residency, Internal Medicine, 2004 - 2006- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2001 - 2002
- University of Chicago (NorthShore)Internship, Transitional Year, 2001 - 2002
University of Illinois College of MedicineClass of 2001- University of Illinois at Urbana-ChampaignBS, Electrical Engineering - Bioengineering, With Highest Honors, 1991 - 1995
- University of Illinois at Urbana-ChampaignBS, School of Life Sciences - Physiology, Magna Cum Laude, 1991 - 1995
Certifications & Licensure
NJ State Medical License 2016 - 2027
MI State Medical License 2009 - 2019
NY State Medical License 2007 - 2018
PA State Medical License 2016 - 2018
IL State Medical License 2004 - 2006
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Certificate of Recognition: Innovator Award DM Clinical Research, 2023
- "Bravo" Award for Service Excellence Oakwood Hospital and Medical Center, 2012
- Electrical Engineering Honor Society Eta Kappa Nu, 1993-1995
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus Start of enrollment: 2016 Apr 01
- Evaluation of Long Term Safety of Tesofensine in Patients With Obesity Start of enrollment: 2007 May 01
Publications & Presentations
Journal Articles
- Ultrasound hyperthermia system for breast cancer treatment.Burdette EC, Bandyopadhyay S, Proceedings of the IEEE Ultrasonics Symposium
- Spatio-Temporal Modelling and Adaptive Acquisition for Cardiac MRI.Aggarwal N, Bandyopadhyay S, and Y Bresler, Proceedings of the International Symposium on Biomedical Imaging
Books/Book Chapters
Research History
- InvestigatorNova 301: Phase III trial of mRNA 1403-P301 vaccine against Norovirus (Moderna).2024 - 2026
- InvestigatorPhase II Trial of JCXH-105-021, RNA vaccine to prevent Shingles, compared to licensed Herpes Zoster Vaccine (Immorna Therapeutics).2022 - 2026
- InvestigatorFluent: a Phase III trial of mRNA 1010-P301 for prevention of influenza (Moderna).2024 - 2025
- Director, Clinical AffairsEarly Feasibility Study of J-Valve in High- & Intermediate-Risk Aortic Regurgitation (JC Medical).2022 - 2022
- Medical Liaisonevoke/evoke+ trials, Phase III Clinical Trial to confirm the effect of oral GLP-1 receptor agonist Semaglutide for the treatment of mild cognitive impairment or mild dementia of Alzheimer’s Type (Novo Nordisk A/S).2022 - 2022
- Protocol and Imaging Charter Committee MemberPhase III Trial of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study of Surrogate Endpoints for Cardiovascular Risks with Treatment of Tesofensine versus Sibutramine in Overweight or Obese Subjects with Hypertension (NeuroSearch A/S).2008 - 2010
- Protocol Committee Member, ANDA SubmissionPhase I Study to establish the bio-availability of controlled-release Naproxen granules compared to twice-a-day Naprosyn in adult patients (STI Pharma, LLC).2007 - 2009
- Protocol Committee Member, NDA SubmissionPhase I/II Clinical Trial of the efficacy and safety of the PPAR-gamma partial agonist Balaglitazone in renal disease (Rheoscience AS).2007 - 2008
- Co-InvestigatorPhase I/II Clinical Trial of "Eagle-Heart", a novel, manganese-based cardiac MRI contrast agent (Bracco Diagnostics and ImaRx Pharmaceuticals).2004 - 2006
Professional Memberships
- Member
- Member
- Member
Other Languages
- Bengali, French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
